Results 221 to 230 of about 68,732 (285)

Guiding the willingness to pay for repurposed tiratricol in the treatment of Allan-Herndon-Dudley syndrome using a cost-based-plus pricing framework

Manders EA, Keestra S, Bannenberg WJ, de Visser SJ, Hollak CE.   +4 more
europepmc   +1 more source

Monoclonal Antibodies (mAbs) and Proteins: The Biologic Drugs Approved by the Food and Drug Administration (FDA) in 2024. [PDF]

Biomedicines
Martins AC, Oshiro MY, Schiavon BN, de Jesus GA, de la Torre BG, Albericio F.   +5 more
europepmc   +1 more source

Letter to the editor regarding a global overview of sickle cell disease: populations, policy limitations and urgent need for comprehensive SCD clinical care, a systematic review. [PDF]

J Sick Cell Dis
Novelli EM.
europepmc   +1 more source

The Effects of Anakinra on Cardiorespiratory Fitness in Heart Failure Stratified by Age in Phase II Clinical Trials. [PDF]

J Cardiovasc Pharmacol
Hogwood AC, Golino M, Moroni F, Canada JM, Del Buono MG, Arena R, Van Tassell B, Abbate A.   +7 more
europepmc   +1 more source

Unlocking access: a comprehensive analysis of medicines accessibility for rare diseases in Thailand. [PDF]

Orphanet J Rare Dis
Suwattanapreeda S, Hirunrassamee S, Sooksriwong C, Maluangnon K, Chuachantra T, Kuchaisit K, Osirisakul N.   +6 more
europepmc   +1 more source

Pharmaceutical governance system for costly drugs through human rights due diligence.

BMJ
Lemmens T, Ghimire KM, Perehudoff K, Kohler JC, Low E, Persaud N.   +5 more
europepmc   +1 more source

Debates over orphan drug pricing: a meta-narrative literature review. [PDF]

Orphanet J Rare Dis
Hanchard MS.
europepmc   +1 more source

Orphan Nuclear Receptors in Metabolic Dysfunction-associated Steatotic Liver Disease Development. [PDF]

J Clin Transl Hepatol
Li H, Chen J, Huang Z, Chen M.
europepmc   +1 more source

Advances and Future Challenges in Microbial Food Safety: Volume I. [PDF]

Foods
Lavilla M, Amárita F.
europepmc   +1 more source

<p>Regulatory networks of HIFs in tumor‑infiltrating immune cells: From molecular mechanisms to therapeutic implications (Review)</p>. [PDF]

Int J Oncol
Li C, Qin C, Li X, Wang J, Li Y, Sun Q.
europepmc   +1 more source